Pfizer, Inc. News Headlines

PFE 
$31.65
*  
0.23
0.73%
Get PFE Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
HDV, T, VZ, PFE: Large Outflows Detected at ETF
12/26/2014 11:16:02 AM - BNK Invest


Dow Movers: BA, PFE
12/26/2014 11:05:03 AM - BNK Invest


After Hours Most Active for Dec 24, 2014 : QQQ, BAC, AIG, GME, INTC, SIRI, ZNGA, HTHT, PFE, CELG, PBR, WFC
12/24/2014 4:21:08 PM - NASDAQ.com News


February 2015 Options Now Available For Pfizer
12/24/2014 3:07:23 PM - BNK Invest


Pfizer's Immunology Pipeline Has Few Bright Spots Besides Xeljanz
12/24/2014 10:21:00 AM - Seeking Alpha


After Hours Most Active for Dec 23, 2014 : OCN, PFE, CSCO, CENX, GME, BCEI, QQQ, INTC, BAC, C, AAPL, MSFT
12/23/2014 4:43:51 PM - NASDAQ.com News


Dow Analyst Moves: PFE
12/23/2014 1:25:08 PM - BNK Invest


Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical
12/23/2014 12:45:00 PM - Seeking Alpha


Dow Movers: MRK, DD
12/23/2014 11:56:18 AM - BNK Invest


It's Official: Zoetis Belongs In Your Dividend Growth Portfolio
12/22/2014 4:46:00 PM - Seeking Alpha


Interesting June 2015 Stock Options for Pfizer
12/22/2014 12:26:28 PM - BNK Invest


European Stocks Seen Rising As Crude Extends Gains
12/22/2014 2:01:00 AM - RTT News


The Most Disappointing Clinical Failures in 2014
12/21/2014 7:32:02 PM - Motley Fool


Update: In A Surprise Twist, AstraZeneca Wins Accelerated FDA Approval For Lynparza
12/21/2014 4:32:00 PM - Seeking Alpha


5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing
12/21/2014 12:42:03 PM - Motley Fool


Why Is George Soros Buying This Beaten Down Biotech Stock?
12/21/2014 11:04:03 AM - Motley Fool


Update: Ligand Wins EU Approval For Duavive
12/21/2014 10:02:00 AM - Seeking Alpha


Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way
12/21/2014 7:14:03 AM - Motley Fool


7 Stocks Providing Their Shareholders A Growing Income With Higher Cash Dividends
12/19/2014 10:11:00 PM - Seeking Alpha


United Therapeutics Lung Drug Keeps Going And Going
12/19/2014 5:20:00 PM - Investor's Business Daily


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.
12/19/2014 7:10:03 AM - Motley Fool


Update: AstraZeneca Wins EU Approval For Lynparza
12/19/2014 1:13:00 AM - Seeking Alpha


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 PM - Zacks.com


Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
12/18/2014 6:48:00 PM - Zacks.com